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ORIGINAL RESEARCH

Sociodemographic and Economic Factors in Outcomes of
Tube Shunts for Neovascular Glaucoma
Wesam S Shalaby1, Amirmohsen Arbabi2, Jonathan S Myers3, Marlene R Moster4, Reza Razeghinejad5, L Jay Katz6,
Aakriti G Shukla7

A b s t r ac t
Importance: Few studies have analyzed associations between sociodemographic factors and neovascular glaucoma (NVG) outcomes.
Aim and background: To determine the potential impact of sociodemographic and economic factors on the NVG tube shunt surgery outcomes.
Design: Retrospective, single-center, comparative case series.
Participants: Consecutive patients who underwent tube shunt surgery for NVG and had ≥6 months of follow-up.
Materials and methods: Regional average adjusted gross income (AGI) was determined by cross-referencing self-reported residential zip
codes with average AGI per zip code supplied by the Internal Revenue Service. Two groups were created: (1) lower-income: individuals from
neighborhoods with the lowest 10% of AGI (near the United States poverty line), (2) higher-income: the remaining 90% of individuals.
Main outcome measures: Visual acuity (VA), intraocular pressure (IOP), and glaucoma medication number at 6 months and the most recent visit.
Results: The mean annual AGI in the higher-income group (130 patients) was $69,596 ± 39,700 and the lower-income group (16 patients) was
$27,487 ± 1,600 (p < 0.001). Age, sex, distance to the clinic, language, and all baseline clinical variables (including VA and IOP) were comparable
between groups. Lower-income was associated with non-white race (81.3 vs 52.3%; p = 0.024). At month 6, VA in the lower-income group
[median: HM (20/70–NLP)] was worse than the higher-income group [median: CF (20/25–NLP)] (log MAR VA: 2.32 ± 0.8 vs 1.77 ± 1.1; p = 0.02);
these trends persisted through the most recent visit (p = 0.043). Follow-up IOP and medications were similar between groups.
Conclusions and relevance: Lower-income may be associated with worse VA outcomes following NVG tube shunt surgery.
Keywords: Ahmed glaucoma valve, Baerveldt glaucoma implant, Glaucoma surgery, Income, Neovascular glaucoma, Race, Sociodemographic,
Socioeconomic, Tube shunt.
Journal of Current Glaucoma Practice (2021): 10.5005/jp-journals-10078-1303

I n t r o d u c t i o n
Neovascular glaucoma (NVG) is a type of secondary glaucoma
that can result in catastrophic vision loss.1 Neovascular glaucoma
is most commonly preceded by proliferative diabetic retinopathy,
central retinal vein occlusion, central retinal artery occlusion, or
ocular ischemic syndrome.1 The management of NVG includes
medical or surgical reduction of intraocular pressure (IOP)
and treatment of the underlying posterior segment ischemiainducing neovascularization. Surgical interventions in the form
of filtering procedures or cyclophotocoagulation are often
necessary when medical therapy fails, especially in the presence
of synechial angle closure. 2 Tube shunt implantation has been
described in several studies as the mainstay of therapy for NVG.3–5
Additionally, underlying retinal ischemia is treated by panretinal
photocoagulation (PRP) and/or intravitreal injection of anti-vascular
endothelial growth factor (anti-VEGF) agents, which reduce
the production of angiogenic factors and induce regression of
neovascularization.6
The impact of sociodemographic and economic factors on
general health outcomes has been widely investigated.7–12 The
prevalence of nearly all chronic conditions, including stroke,
heart disease, and arthritis has been shown to increase as income
declines.7 Economic inequality in the United States is among the
highest of developed nations, and there is a life expectancy gap of
10–15 years between the wealthiest and poorest 1% of the American
population.11,12 In addition to income, factors including race, sex,
ethnicity, primary language, education, housing, employment,
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and health insurance status have been shown to have a significant
association with general health outcomes.13–19
The literature on associations between sociodemographic
and economic factors and ophthalmic health outcomes is
limited.13–18 Healthcare disparities in ophthalmology have been
associated with race, sex, education, and income.13–16 Although
NVG is common secondary glaucoma and tends to affect those
with poor general health,1 few studies have analyzed associations
between sociodemographic factors and NVG outcomes. This study
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Sociodemographic and Economic Factors in NVG Surgical Outcomes
aimed to investigate a potential relationship between income and
visual acuity (VA) and IOP outcomes after glaucoma tube shunt
implantation in patients with NVG.

M at e r ia l s

and

M e t h o d s

Study Design
This was a single-center, retrospective comparative case series.
The study was approved by the Institutional Review Board of
Wills Eye Hospital and was in accordance with Health Insurance
Portability and Accountability Act Regulations. As this was a
retrospective study with de-identified data, informed consent
was not required. The medical records of consecutive patients
diagnosed with NVG who were treated at Wills Eye Hospital with
a glaucoma tube shunt [Ahmed glaucoma valve (New World
Medical Inc., Rancho Cucamonga, CA, USA) or Baerveldt glaucoma
implant (Advanced Medical Optics, Santa Ana, CA, USA)] between
2007 and 2019 were reviewed. Patients who had undergone
tube shunt surgery for NVG in both eyes only had the first eye
included. The diagnosis of NVG was based on the presence of
neovascularization of the iris and/or anterior chamber angle and
IOP >21 mm Hg. Neovascular glaucoma was considered refractory
if the IOP was too high for the health of the optic nerve despite
maximal tolerated medical therapy.
The yearly regional average adjusted gross income (AGI)
was determined by cross-referencing the patient’s self-reported
residential zip code with the average AGI per zip code supplied
by the Internal Revenue Service. Distance to Wills Eye Hospital
was calculated using Google Maps (www.maps.google.com) by
measuring the distance between the center of the patient’s selfreported zip code and 840 Walnut Street, Philadelphia, Pennsylvania
(location of Wills Eye Hospital). Two groups were created: lower
AGI group—those living in neighborhoods with the lowest 10%
of AGI (N = 16) with an average household income of $27,500 ±
1,600, and higher AGI group—the remaining 90% of individuals
(N = 130) with an average household income of 69,600 ± 39,700.
The United States government’s federal poverty line is one of the
most commonly-used markers of poverty and is calculated by
finding the total cost of all the essential resources that an average
human adult consumes in 1 year. Our classification was based on
the United States poverty line guidelines in 2020, which classified
a family of four with a household income of $26,200 as “poor”.
The lower-income group represented individuals who lived in
neighborhoods with an average AGI near the United States poverty
line, while the higher-income group represented those above the
United States poverty line.19,20

Inclusion and Exclusion Criteria
Patients aged 18 years or older with refractory NVG (defined above)
requiring glaucoma tube shunt surgery were included in the study.
Exclusion criteria included patients with no light perception vision at
baseline, prior tube shunt implantation or cyclophotocoagulation,
and follow-up duration <6 months. Prior trabeculectomy or other
non-glaucoma surgery, including cataract and vitreoretinal surgery,
were not considered exclusionary criteria.

Patient Visits
Medical records were reviewed for the preoperative visit, as well as
visits at postoperative day 1, week 1, months 1, 3, 6, and the most
recent visit. Demographic data such as age, sex, race, and preferred
language as well as medical and surgical history were collected.

Preoperative clinical data included VA, IOP, number of glaucoma
medications, lens status, presence of peripheral anterior synechiae,
and/or hyphema. Details of neovascular disease including laterality,
NVG etiology, laterality of the underlying retinal pathology, and
retinal treatment in the form of PRP or intravitreal injection of antiVEGF within 2 weeks of surgery were also identified at baseline.
Postoperative data included VA, IOP, and the need for glaucoma
medications.

Outcome Measures
The primary outcome measures were VA, IOP, and the number
of glaucoma medications at 6 months and the most recent visit.
The severity of visual loss was also investigated. Visual loss was
categorized according to the best-corrected Snellen VA into mild to
moderate (≥20/200) or severe (<20/200) vision loss. Postoperative
month 6 failure was defined as IOP >21 mm Hg on maximum
tolerated medical therapy or <5 mm Hg with visual complications
on two consecutive visits, progression to no light perception vision,
and reoperation for glaucoma.

Statistical Analysis
Statistical analyses were performed using SPSS software version
27.0 (IBM Analytics, Chicago, IL, USA). One eye from each patient
was chosen for inclusion; if a patient had tube shunt surgery in both
eyes or multiple tube shunts in the same eye, the first eye and the
first tube shunt were chosen for inclusion. Snellen VA measurements
were converted to logarithm of the minimum angle of resolution
(log MAR) VA equivalents for data analysis. Measures of center
and dispersion were presented as mean ± standard deviation.
Proportions (%) were used to describe categorical variables.
Two-sided Student’s t-tests and Chi-square tests (Fisher’s exact
tests) were used to compare treatment groups for continuous and
categorical variables, respectively. Paired sample t-tests and the
McNemar test were used to compare continuous and categorical
variables within the same group, respectively. p values <0.05 were
considered significant.

R e s u lts
Baseline Characteristics
Baseline characteristics of both groups are displayed in Table 1. A
total of 146 eyes of 146 patients with an average follow-up duration
of 28.5 ± 25.4 months were included. Mean AGI in the higher
income group (130 patients) was $69,596/year ± 39,700 and the
lower-income group (16 patients) was $27,487/year ± 1,600 (p <
0.001). Patient demographics including age, sex, and distance to
Wills Eye Hospital were comparable between groups. The preferred
language as non-English was more common in the lower-income
group (25.0 vs 13.8%), however, this difference was not significant
(p = 0.265). Racial variations between both groups were present,
but not significant (p = 0.055). When the race was presented as
white vs non-white, the lower-income group had a significantly
greater proportion of non-white individuals compared with the
higher-income group (81.3 vs 52.3%; p = 0.024). Preoperative VA,
IOP, number of glaucoma medications, lens status, presence of
hyphema, an extension of synechial angle closure, NVG etiology,
unilateral or bilateral underlying ischemic retinal pathology, choice
of tube type, surgery by attending physicians vs trainees, and
average follow-up duration were similar in both groups. Retinal
treatment within 2 weeks of surgery with PRP or intravitreal
injection of anti-VEGF was similar between groups.
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Table 1: Baseline patient characteristics in the lower and higher average gross income groups
Age, years
Sex: females
Race: all

White
Black
Asian
Hispanic
Indian
Unknown
Race: white vs non-white
White
Non-white
Language
English
Non-English
Average gross income, $ in thousands
Distance from Wills Eye Hospital, Miles
Tube type: Ahmed
Surgeon
Trainee
Attending
Surgical eye: right
NVG etiology
PDR
CRVO
CRAO
OIS
Unknown
Combined
Bilateral underlying ischemic retinal pathology
Preoperative visual acuity
Log MAR
Snellen median
Snellen range
Preoperative IOP, mm Hg
Number of preoperative medications
Preoperative lens status
+1–2 Cataract
+3–4 Cataract
Pseudophakia
Aphakia
Preoperative hyphema
Preoperative peripheral anterior
None
synechiae
<180°
180–270°
360°
No view
PRP within 2 weeks of surgery
Intravitreal injection within 2 weeks of surgery
Overall retina treatment within 2
None
weeks of surgery
Intravitreal injection or PRP
Intravitreal injection and PRP
Follow-up duration, months

Lower AGI (N = 16)
60.0 ± 13.5
6 (37.5)
3 (18.8)
5 (31.3)
0 (0.0)
3 (18.8)
0 (0.0)
5 (31.3)
3 (18.8)
13 (81.3)
12 (75.0)
4 (25.0)
27.5 ± 1.6
12.4 ± 15.4
11 (68.8)
10 (62.5)
6 (37.5)
7 (43.8)
9 (56.3)
5 (31.3)
0 (0.0)
0 (0.0)
1 (6.3)
1 (6.3)
9 (65.3)
2.11 ± 1
HM
20/30–LP
41.8 ± 13.3
3.1 ± 1.0
9 (56.3)
1 (6.3)
6 (37.5)
0 (0.0)
2 (12.5)
1 (6.3)

Higher AGI (N = 130)
65.4 ± 14.3
49 (37.7)
62 (47.7)
38 (29.2)
6 (4.6)
7 (5.4)
1 (0.8)
16 (12.3)
62 (47.7)
68 (52.3)
112 (86.2)
18 (13.8)
69.6 ± 39.7
29.9 ± 47.5
82 (63.1)
50 (38.5)
80 (61.5)
64 (49.2)
76 (58.5)
32 (24.6)
8 (6.2)
3 (2.3)
3 (2.3)
8 (6.2)
74 (56.9)
1.91 ± 0.9
CF
20/25–LP
39.9 ± 11.4
3.4 ± 0.8
55 (42.3)
9 (6.9)
65 (50.0)
1 (0.8)
23 (17.7)
11 (8.5)

Total (N = 146)
64.8 ± 14.3
55 (37.7)
65 (44.5)
43 (29.5)
6 (4.1)
10 (6.8)
1 (0.7)
21 (14.4)
65 (44.5)
81 (55.5)
124 (84.9)
22 (15.1)
65.0 ± 39.7
28.0 ± 45.4
93 (63.7)
60 (41.1)
86 (58.9)
71 (48.6)
85 (58.2)
37 (25.3)
8 (5.5)
3 (2.1)
4 (2.7)
9 (6.2)
83 (56.8)
1.94 ± 0.9
CF
20/25–LP
40.1 ± 11.6
3.4 ± 0.8
64 (43.8)
10 (6.8)
71 (48.6)
1 (0.70)
25 (17.1)
12 (8.2)

0.603
0.277

0 (0.0)
2 (12.5)
5 (31.3)
8 (50.0)
13 (81.3)
11 (68.8)
2 (12.5)

15 (11.5)
24 (18.5)
46 (35.4)
34 (26.2)
87 (66.9)
91 (70.0)
15 (11.5)

15 (10.3)
26 (17.8)
51 (34.9)
42 (28.8)
100 (68.5)
102 (69.9)
17 (11.6)

0.244
0.918
0.494

4 (25.0)
10 (62.5)
28.5 ± 26.4

52 (40.0)
63 (48.5)
28.5 ± 25.4

56 (38.4)
73 (50.0)
28.5 ± 25.4

0.999

p value
0.157
0.608
0.055

0.024
0.265
<0.001
0.148
0.441
0.104
0.442
0.788

0.959
0.426

0.531
0.251
0.748

AGI, average gross income; NVG, neovascular glaucoma; IOP, intraocular pressure; Log MAR, logarithm of the minimum angle of resolution; PDR, proliferative diabetic retinopathy; CRVO, central retinal vein occlusion; CRAO, central retinal artery occlusion; OIS, ocular ischemic syndrome; PRP, panretinal
photocoagulation; CF, counting fingers; HM, hand motion, LP, light perception
Parentheses denote percentages
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Outcome Measures
The outcome measures at postoperative month 6 and most recent
visits are displayed in Table 2. At postoperative month 6, VA in
the lower-income group (median: HM, range: 20/70–NLP) was
significantly lower than the higher-income group (median: CF,
range: 20/25–NLP) (mean log MAR VA: 2.32 ± 0.8 vs 1.77 ± 1.1; p =
0.02). This trend continued through the most recent visit with lower
VA in the lower-income group (median: HM, range: 20/100–NLP)
compared with the higher-income group (median: CF, range: 20/25–
NLP) (mean log MAR VA: 2.41 ± 0.8 vs 1.93 ± 1.1; p = 0.043) (Fig. 1).
Progression to severe vision loss is displayed in Supplemental
Table 1. In the lower-income group, 75.0% of patients had severe
vision loss at baseline, which increased to 81.3% at postoperative
month 6 (p = 1.00) and further increased to 87.5% at the most recent
visit (p = 0.500). On the other hand, 70.0% of patients in the higher
income group had severe vision loss at baseline, but many of them
achieved significant improvement at postoperative month 6 visit,
reducing severe vision loss to 58.5% (p = 0.003). At the most recent
visit, 64.6% of the higher income group had severe vision loss, which

Fig. 1: Visual Acuity Changes over time in the lower and higher average
growth income (AGI) groups

Table 2: Month 6 and final outcomes in the lower and higher average gross income groups
Month 6 visual acuity

Month 6 IOP, mm Hg
Month 6 lens status

Log MAR
Snellen median
Snellen range

+1–2 Cataract
+3–4 Cataract
Pseudophakia
Aphakia
Number of month 6 medications
Month 6 reoperation
Month 6 failure
3 (18.8)
Reasons for failure
IOP >21 mm Hg
Loss of LP vision
Reoperation
IOP <5 mm Hg
Combined
Month 6 reoperation
Month 6 complications
Hypotony
Suprachoroidal hemorrhage
Tube erosions
Endophthalmitis
Final visit visual acuity
Log MAR
Snellen median
Snellen range
Final visit IOP, mm Hg
Final visit number of medications
Final visit lens status
+1–2 Cataract
+3–4 Cataract
Pseudophakia
Aphakia

Lower AGI (N = 16)
2.32 ± 0.8
HM
20/70–NLP
16.0 ± 6.1
6 (37.5)
2 (12.5)
7 (43.8)
1 (6.3)
1.5 ± 1.3
1 (6.3)
31 (23.8)
1 (33.3)
1 (33.3)
0 (0.0)
0 (0.0)
1 (33.3)
1 (6.3)
0 (0.0)
0 (0.0)
1 (6.3)
0 (0.0)
2.41 ± 0.8
HM
20/100–NLP
16.1 ± 7.2
1.7 ± 1.3
5 (31.3)
3 (18.8)
7 (43.8)
1 (6.3)

Higher AGI (N = 130)
1.77 ± 1.1
CF
20/25–NLP
16.8 ± 7.4
47 (36.2)
8 (6.2)
73 (56.2)
2 (1.5)
2.0 ± 1.4
3 (2.3)
34 (23.3)
22 (71.0)
5 (16.1)
2 (6.5)
1 (3.2)
1 (3.2)
3 (2.3)
1 (0.8)
8 (6.2)
2 (1.5)
0 (0.0)
1.93 ± 1.1
CF
20/25–NLP
16.4 ± 8.3
2.1 ± 1.6
34 (26.2)
12 (9.2)
80 (61.5)
4 (3.1)

Total (N = 146)
1.82 ± 1.0
CF
20/25–NLP
16.7 ± 7.2
53 (36.3)
10 (6.8)
80 (54.8)
3 (2.1)
1.9 ± 1.4
4 (2.7)
0.649
23 (67.6)
6 (17.6)
2 (5.9)
1 (2.9)
2 (5.9)
4 (2.7)
1 (0.7)
8 (5.5)
3 (2.1)
0 (0.0)
1.98 ± 1.0
CF
20/25–NLP
16.3 ± 8.2
2.1 ± 1.5
39 (26.7)
15 (10.3)
87 (59.6)
5 (3.4)

p value
0.020

0.691
0.426

0.247
0.362
0.237

0.375
1.00
0.599
0.269
–
0.043

0.916
0.262
0.463

AGI, average gross income; Log MAR, logarithm of the minimum angle of resolution; IOP, intraocular pressure; LP, light perception; CF, counting fingers;
HM, hand motion; NLP, no light perception
Parentheses denote percentages
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D i s c u s s i o n

Fig. 2: Progression to severe vision loss over time in the lower and higher
average growth income (AGI) groups

was an improvement from their baseline (70.0%) but did not reach
significance (p = 0.248). In comparing vision loss between the two
groups, severe vision loss was greater in the lower-income group
compared with the higher-income group at month 6 (81.3 vs 58.5%,
respectively) and month 12 (87.5 vs 64.6%, respectively) but this
difference was not statistically significant (Fig. 2). The disparities
in severe vision loss were unlikely to be due to differences in lens
status, as this was similar between the two groups at month 6
(p = 0.426) and the most recent visit (p = 0.463). Additionally, at
postoperative month 6, 34 (23.3%) patients met the failure criteria,
with no difference between income groups (p = 0.649). Reasons
for failure were also similar between income groups (p = 0.237),
with IOP >21 mm Hg the most common reason (67.6%) followed by
loss of light perception (17.6%). Reoperation for glaucoma (second
tube shunt or cyclophotocoagulation) at month 6 was required in
one case in the lower-income group and three cases in the higherincome group with no significant difference (p = 0.375). Serious
postoperative complications within 6 months postoperatively
including hypotony (p = 1.00), suprachoroidal hemorrhage (p =
0.599), and tube erosions (p = 0.269) were also similar between the
two groups, with no endophthalmitis in either group.
No difference in the IOP or medication use was detected
between the higher- and lower-income groups at postoperative
month 6 or the most recent visit (p > 0.05 for both). Both groups
experienced a significant reduction in the IOP and medication
number at postoperative month 6 and most recent visits. The
lower-income group experienced an IOP reduction from baseline to
postoperative month 6 (41.1 ± 12.4 vs 16.0 ± 6.1 mm Hg; p < 0.001),
which was maintained at the most recent visit (41.1 ± 12.4 vs 16.1 ±
7.2 mm Hg; p < 0.001). The lower-income group’s medication use
was also reduced from baseline to postoperative month 6 (3.1 ± 1.0
vs 1.5 ± 1.3; p < 0.001), which was maintained at the most recent
visit (3.1 ± 1.0 vs 1.7 ± 1.3; p = 0.002). The higher-income group
experienced an IOP reduction from baseline to postoperative
month 6 (39.9 ± 11.4 vs 16.8 ± 7.4 mm Hg; p < 0.001), which was
maintained at the most recent visit (39.9 ± 11.4 vs 16.4 ± 8.3 mm
Hg; p < 0.001). The higher-income group’s medication use was also
reduced from baseline to postoperative month 6 (3.4 ± 0.8 vs 2.0 ±
1.4; p < 0.001), which was maintained at the most recent visit (3.4 ±
0.8 vs 2.1 ± 1.6; p < 0.001).
74

Higher burdens of illness, disability, and mortality have been
associated with lower socioeconomic status across the medical
specialties. 7–12 The ophthalmic literature on the association
between sociodemographic and economic factors and clinical
presentation,18,21,22 surgical outcomes,17 and adherence to
treatment is limited.23,24 Our study analyzed a possible relationship
between income and outcomes after surgery for NVG and found
that despite similar preoperative characteristics in the two groups,
those with lower income had significantly worse VA at postoperative
month 6 and at their most recent visit.
To our knowledge, ours is the first study to investigate the
association between sociodemographic and economic factors
and surgical outcomes in NVG. Preoperative severe vision loss
was dominant in both groups (75.0 and 70.0% in the lower- and
higher-income groups, respectively, p = 0.679). However, the
higher-income group experienced significant improvement in VA
by postoperative month 6, while those in the lower-income group
had increasingly larger proportions of severe vision loss over time.
The potential reasons for these disparate outcomes are many. First,
reversible causes of poor vision (e.g., corneal edema) before surgery
may have led to decreased VA in the higher income group. Initial
severe vision loss may have been due to reversible and irreversible
causes including corneal edema, macular edema and/or ischemia,
vitreous hemorrhage, and glaucoma. It is possible that the higher
income group had more reversible causes of visual loss as their VA
improved over the course of the study. Of note, the presence of
cataracts at all time points was similar between the two groups,
making it unlikely that lens opacity was more likely to be the
etiology of worsening vision.
Additionally, the lower-income group may have had more
severe retinal pathology at baseline or may have presented later
in the course of disease with significant optic nerve damage and/
or retinal ischemia. Our tertiary care center often receives urgent
referrals for NVG patients from outside practices where patients may
have initially presented, making it difficult to know the duration of
NVG and retinal pathology, both of which may have had an impact
on final VA outcomes. Poor outcomes may have been associated
with more advanced presentation. Moreover, while both groups
received similar perioperative retinal treatment (PRP or intravitreal
injection within 2 weeks of surgery), it is possible that the lowerincome group was not able to continue close retinal follow-up,
although adherence to glaucoma visits was similar between the
two groups. Notably, IOP reduction, 6-month surgical failure, and
surgical complications were similar for both groups at all time
points. Furthermore, the difference in the proportions of trainees
performing surgery in each group was not statistically significant,
and a prior study has shown that tube shunt surgery performed
by residents are as effective and safe as surgeries performed by
attendings.25
Furthermore, the lower-income group had a higher proportion
of non-white race (p = 0.024), which may have affected surgical
outcomes. Previous studies have suggested that the black race
may be associated with a higher failure rate after trabeculectomy
or tube shunt surgery, however, this is controversial.26–30 Studies
on intravitreal injections to treat proliferative diabetic retinopathy
and retinal vein occlusion have suggested that African Americans
and those with lower income are vulnerable to poor follow-up.23,24
Notably, NVG is most commonly caused by these ischemic
disorders,1 which suggests that these results may be applied to NVG
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patients as well. Although we included patients who had at least
6 months of follow-up with the glaucoma service after the tube
shunt surgery, we did not investigate their postoperative retinal
treatment schedule. Long-term adherence to repeated retinal
treatment may have varied between the lower- and higher-income
groups and may be reflected on their visual outcomes despite
similar IOP control. Although the language may represent a barrier
to healthcare access, potentially increasing the incidence of disease
complications,3 our sample showed no difference between the
higher- and lower-income groups regarding the prevalence of the
non-English speakers (p = 0.265).
Previous studies have investigated the impac t
of sociodemographic and economic status on ophthalmic
outcomes.17,18,21,22 Socioeconomic deprivation and AfricanCaribbean race have previously been associated with advanced
disease on presentation, making these groups more likely to
experience major vision loss from glaucoma.21,22 Likewise, adverse
economic conditions have been associated with blindness in NVG
patients.32 Moreover, studies on age-related macular degeneration
have demonstrated that lower-income and non-white races are risk
factors for severe vision loss at presentation.18 Similarly, these are
risk factors for the fovea-off presentation of rhegmatogenous retinal
detachment, subsequent higher risk of reoperation, and worse
postoperative VA.17 Furthermore, a systematic review of studies that
evaluated major acquired causes of visual loss (including cataract,
diabetic eye disease, glaucoma, age-related macular degeneration,
and ocular trauma) reported a higher risk of vision loss between
these disease entities and socioeconomic deprivation.33 While the
disease process studied in our report is distinct from prior studies on
income and health outcomes, a trend of worse VA outcomes in those
with a lower income is consistent across the literature. Our findings
suggest that NVG patients are also subject to these unfortunate
associations between socioeconomic status and ocular health.
This study is not without limitations. These include its
retrospective design and lack of information about diabetic
control (as tight glycemic control in diabetic patients slows the
progression of diabetic retinopathy with subsequent NVG34), and
the inclusion of both Baerveldt glaucoma implants and Ahmed
glaucoma valves. Additionally, this study, similar to those previously
published,17,18,23,24 used Internal Revenue Service data to calculate
income, as opposed to patients’ reports of income. Additionally,
as we were comparing 10% of the sample to the remaining 90%,
sample sizes were not balanced between the groups, which may
have limited our ability to detect differences. Strengths include a
considerable sample size given the subject matter and inclusion
of consecutive patients.

C o n c lu s i o n
To our knowledge, this is the first study to investigate an association
between sociodemographic and economic factors and surgical
outcomes in NVG. Our findings suggest that patients from
neighborhoods with an average income near the United States
poverty line are at higher risk of worse VA outcomes following
tube shunt surgery for NVG than patients from more affluent
neighborhoods. We further demonstrate that sociodemographic
and economic inequalities are associated with health outcomes.
Additional study on this potential association is warranted and may
help guide clinicians in counseling patients and provide further
insight regarding reasons for worse visual outcomes in the most
vulnerable populations.

C l i n i c a l S i g n i f i c a n c e
To our knowledge, this is the first study to investigate an
association between sociodemographic and economic factors
and surgical outcomes in NVG. This investigation demonstrated
the potential relationship between low income and poor visual
outcomes in NVG.
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Supplementary Table 1: Progression of severe vision loss in the lower and higher
average gross income groups at month 6 and final visits compared to baseline

Lower AGI group

Preoperative severe
vision loss
12 (75)

Higher AGI group

91 (70)

Month 6 severe
vision loss
13 (81.3)
p = 1.00
76 (58.5)
p = 0.003

Final severe
vision loss
14 (87.5)
p = 0.500
84 (64.6)
p = 0.248

AGI, average gross income
Parentheses denote percentages
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